Cancer Incidence Among Users of Glucagon-Like Peptide-1 Receptor Agonists

• by Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Abdullah Altaf, Shahzaib Zindani, Areesh Mevawalla, Azza Sarfraz, Khalid Mumtaz, Timothy M. Pawlik

• February 26, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min

I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

• by Jody Dushay

• May 29, 2026

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

• May 27, 2026

• 3 min